Implexis
PrivateLast Round
Seed
Jun 15, 2026
Total Funding Raised
$330,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Implexis is a biotechnology company that provides a proprietary platform to accelerate drug formulation development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Vertical SaaS, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Implexis Comparables
Compare Implexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Persist AI | 80% | |
| Intrepid Labs | 79% | |
| VeriSIM Life | 77% | |
Implexis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 15, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 15, 2026
$330K raised in Seed round.
Implexis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Implexis's valuation, stock price, and market status.